ツムラの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2025/02/18 | 4,493 | 4,504 | 4,362 | 4,400 | -91 | -2% | 178,900 |
| 2025/02/17 | 4,493 | 4,568 | 4,484 | 4,491 | +7 | +0.2% | 245,500 |
| 2025/02/14 | 4,497 | 4,536 | 4,468 | 4,484 | +57 | +1.3% | 284,000 |
| 2025/02/13 | 4,499 | 4,499 | 4,378 | 4,427 | +67 | +1.5% | 280,400 |
| 2025/02/12 | 4,421 | 4,421 | 4,303 | 4,360 | -43 | -1% | 386,000 |
| 2025/02/10 | 4,395 | 4,469 | 4,357 | 4,403 | +78 | +1.8% | 310,800 |
| 2025/02/07 | 4,266 | 4,387 | 4,248 | 4,325 | +59 | +1.4% | 538,600 |
| 2025/02/06 | 4,489 | 4,718 | 4,106 | 4,266 | -196 | -4.4% | 1,034,000 |
| 2025/02/05 | 4,456 | 4,475 | 4,420 | 4,462 | +3 | +0.1% | 175,800 |
| 2025/02/04 | 4,552 | 4,552 | 4,446 | 4,459 | +15 | +0.3% | 214,200 |
| 2025/02/03 | 4,545 | 4,545 | 4,419 | 4,444 | -136 | -3% | 265,300 |
| 2025/01/31 | 4,581 | 4,632 | 4,565 | 4,580 | +5 | +0.1% | 188,500 |
| 2025/01/30 | 4,555 | 4,579 | 4,550 | 4,575 | +14 | +0.3% | 104,900 |
| 2025/01/29 | 4,610 | 4,619 | 4,551 | 4,561 | +6 | +0.1% | 181,600 |
| 2025/01/28 | 4,545 | 4,577 | 4,530 | 4,555 | -5 | -0.1% | 174,200 |
| 2025/01/27 | 4,558 | 4,563 | 4,511 | 4,560 | +32 | +0.7% | 133,700 |
| 2025/01/24 | 4,561 | 4,575 | 4,517 | 4,528 | +15 | +0.3% | 178,800 |
| 2025/01/23 | 4,485 | 4,521 | 4,480 | 4,513 | -5 | -0.1% | 138,800 |
| 2025/01/22 | 4,495 | 4,551 | 4,495 | 4,518 | +13 | +0.3% | 167,900 |
| 2025/01/21 | 4,458 | 4,508 | 4,458 | 4,505 | +36 | +0.8% | 156,500 |
| 2025/01/20 | 4,511 | 4,515 | 4,457 | 4,469 | -42 | -0.9% | 157,000 |
| 2025/01/17 | 4,480 | 4,558 | 4,480 | 4,511 | +33 | +0.7% | 130,300 |
| 2025/01/16 | 4,515 | 4,537 | 4,478 | 4,478 | -37 | -0.8% | 144,200 |
| 2025/01/15 | 4,560 | 4,572 | 4,494 | 4,515 | -61 | -1.3% | 203,100 |
| 2025/01/14 | 4,630 | 4,645 | 4,558 | 4,576 | -80 | -1.7% | 205,600 |
| 2025/01/10 | 4,684 | 4,701 | 4,648 | 4,656 | -54 | -1.1% | 214,000 |
| 2025/01/09 | 4,712 | 4,729 | 4,672 | 4,710 | -2 | ±0% | 144,300 |
| 2025/01/08 | 4,686 | 4,728 | 4,673 | 4,712 | +9 | +0.2% | 145,300 |
| 2025/01/07 | 4,685 | 4,775 | 4,680 | 4,703 | +28 | +0.6% | 214,800 |
| 2025/01/06 | 4,737 | 4,747 | 4,674 | 4,675 | -33 | -0.7% | 178,400 |
| 2024/12/30 | 4,736 | 4,759 | 4,705 | 4,708 | -34 | -0.7% | 161,700 |
| 2024/12/27 | 4,702 | 4,742 | 4,677 | 4,742 | +31 | +0.7% | 178,800 |
| 2024/12/26 | 4,698 | 4,720 | 4,686 | 4,711 | +36 | +0.8% | 124,300 |
| 2024/12/25 | 4,690 | 4,698 | 4,611 | 4,675 | -51 | -1.1% | 239,200 |
| 2024/12/24 | 4,701 | 4,746 | 4,698 | 4,726 | ±0 | ±0% | 186,200 |
| 2024/12/23 | 4,800 | 4,847 | 4,696 | 4,726 | -121 | -2.5% | 356,700 |
| 2024/12/20 | 4,800 | 4,856 | 4,776 | 4,847 | +78 | +1.6% | 212,800 |
| 2024/12/19 | 4,722 | 4,790 | 4,720 | 4,769 | -23 | -0.5% | 181,400 |
| 2024/12/18 | 4,860 | 4,880 | 4,757 | 4,792 | -46 | -1% | 212,800 |
| 2024/12/17 | 4,825 | 4,880 | 4,815 | 4,838 | +6 | +0.1% | 129,900 |
| 2024/12/16 | 4,878 | 4,900 | 4,829 | 4,832 | -37 | -0.8% | 199,300 |
| 2024/12/13 | 4,770 | 4,886 | 4,766 | 4,869 | +45 | +0.9% | 223,800 |
| 2024/12/12 | 4,828 | 4,877 | 4,819 | 4,824 | +22 | +0.5% | 208,500 |
| 2024/12/11 | 4,792 | 4,825 | 4,777 | 4,802 | -2 | ±0% | 139,000 |
| 2024/12/10 | 4,909 | 4,918 | 4,779 | 4,804 | -78 | -1.6% | 210,800 |
| 2024/12/09 | 4,895 | 4,920 | 4,861 | 4,882 | +14 | +0.3% | 158,000 |
| 2024/12/06 | 4,883 | 4,904 | 4,827 | 4,868 | -22 | -0.4% | 148,300 |
| 2024/12/05 | 4,929 | 4,933 | 4,875 | 4,890 | -5 | -0.1% | 171,900 |
| 2024/12/04 | 4,896 | 4,939 | 4,833 | 4,895 | -39 | -0.8% | 244,500 |
| 2024/12/03 | 4,960 | 4,999 | 4,915 | 4,934 | +44 | +0.9% | 276,100 |
51～
100
件表示中 / 3692件
類似銘柄と比較する
現在ご覧いただいている「ツムラ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| ツムラ | 430,100円 | +20.9% | +87.3% | 3.16% | 9.61倍 | 1.11倍 |
|
医療用漢方薬で国内シェア８割超。高齢者、がん支持療法、女性関連の３領域を重点に市場深耕 |
| 久光薬 | 443,700円 | +5.8% | +1.2% | 2.70% | 14.72倍 | 1.17倍 |
|
貼る鎮痛消炎剤首位。医療用シェア５割。大衆薬「サロンパス」で有名。米国、中国など海外強化 |
| 住友ファーマ | 94,100円 | +26.8% | - | 0.00% | 15.84倍 | 3.27倍 |
|
医薬品準大手、住友化学傘下。買収で米国へ展開。研究開発は精神神経、がん、再生細胞に重点 |
| ペプチド | 201,800円 | +5.0% | +1.5% | 0.00% | 17.33倍 | 4.61倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
| 日本新薬 | 373,500円 | +7.9% | +8.9% | 3.32% | 7.99倍 | 1.07倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
市場注目の銘柄
チャート関連のコラム
